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Class I loci (K, D, and L of the murine MHC [H-2]) encode for molecules that 
are important in the interaction between virus-specific antigen and T-cytotoxic 
(Tc) effector cells. This interaction appears to be accomplished by T-cytotoxic 
effector cell recognition of both target H-2K/D gene products and antigen (1- 
3). Several virus-induced phenomena associated with immune function have been 
mapped to class I loci, particularly the H-2D end (3). The H-2D region harbors 
a group of genes that influences resistance to oncovirus-induced neoplasms such 
as Friend virus mouse leukemia (4,  5), murine Moloney virus leukemia (6), and 
radiation leukemia virus-induced tumorigenesis (7, 8). The H-2D region genes 
also  have  been  implicated  in  susceptibility  to  autoimmune  diseases  such  as 
experimental autoimmune thyroiditis (9). These immunogenetic studies suggest 
that one of the H-2D region genes or genes in close proximity may modulate the 
immune response of the host to a foreign virus-specific antigen or self antigen. 
Theiler's murine encephalomyelitis (TME) 1 is an important model for study 
of viral persistence in the nervous system and immune-mediated demyelination 
(10,  11).  This  naturally  occurring  disease  in  mice  has  been  considered  an 
excellent model for multiple sclerosis because demyelination in the human disease 
may be  the result of an  immune-mediated response  triggered by a  persistent 
virus. The destruction of white matter is associated with inflammatory cells which 
play an active role in  myelin breakdown.  Also,  the lesions are fewer and  less 
severe in TME virus-infected (TMEV-infected) mice treated with immunosup- 
pressive agents (12, 13) or with mAb directed at immune response gene products 
(14).  Earlier  studies  demonstrated a  wide  range  of genetic susceptibilities  to 
TMEV-induced demyelination in mice from different strains (15,  16). We have 
shown, using morphoiogic criteria, that mice with similar genetic backgrounds, 
but  different H-2  haplotypes,  have different susceptibilities  to  demyelination 
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(17).  Light and electron  microscopy of spinal cord sections from mice with s, f, 
p,  r,  v,  or  q  haplotype  on  a  C57BL/10  background  showed  areas  of primary 
demyelination  in  association  with  perivascular  inflammation.  In  contrast,  mice 
with  identical  backgrounds  but  b,  k,  or  d  haplotype  showed  no  pathologic 
abnormalities in the white matter. 
The  present  study  was  done  to  map  the  susceptible  genes  within  the  H-2 
complex. Using mouse strains with congeneic recombinant haplotypes, we dem- 
onstrate  that  the  D  region  of the  H-2  complex  is  primarily  responsible  for 
determining susceptibility or resistance to TMEV infection. In addition, mutation 
of the  H-2D genes alters susceptibility to virus-induced demyelination.  We also 
correlate the ability of TMEV  to persist in  the central  nervous system and  the 
TMEV-specific humoral response with genetic susceptibility. 
Materials and  Methods 
Virus.  The Daniels (DA) strain  of TMEV was used for all  experiments.  The origin 
and passage history of the virus has been described (18-20).  The brain and spinal cord 
from infected mice were assayed for virus by a plaque method on L2 cells (21).  Virus for 
use as antigen was purified from infected BHK-21 cells by ultracentrifugation on cesium 
chloride density gradients. 
ELISA To Detect TMEV-specific Antibody.  Serum IgG directed against purified DA strain 
virus antigen was determined by EL1SA. Purified DA antigen (100 ng/well) was adsorbed 
to  96-well  microtest  tissue  culture  plates  (Falcon  Labware,  Oxnard,  CA).  The  excess 
binding sites were saturated with  1%  BSA. Plates were filled with 50%  glycerol in PBS 
and stored frozen at -80 °C. 
Before the assay, plates were thawed and washed in 0.01  M PBS/0.05% Tween buffer 
(pH 7.4).  Multiple serial dilutions of the test sera (1:800 to 1:12, 800 in PBS) were made 
and 100 #1 was added to individual wells; then the plates were incubated for 2 h at 37°C. 
After thorough  washing of the plates,  100 #1 of a  1:I,000 dilution  of goat anti-mouse 
IgG conjugated to alkaline phosphatase (Sigma Chemical Co., St. Louis, MO) was added; 
incubation  was  for  2  h  at  37°C.  After  washing,  100  ul  of Sigma Chemical  Co.  104 
phosphatase substrate was added and incubation was for 30 rain. The OD at 410 nm was 
read in  an  MR  600  microplate reader (Dynatech  Laboratories, Inc., Alexandria,  VA). 
Sera from a known hyperimmune positive control as well as sera from noninfected mice 
were run with each plate. 
Animals and Experimental Protocol.  All mice were raised in the Mayo immunogenetic 
mouse colony. 4-10-wk-old female mice were inoculated  intracerebrally with  2  ×  105 
PFUs  of DA  virus  in  a  total  volume of  10  #l.  5-20  animals  from each  strain  were 
inoculated and examined daily for clinical signs of infection. All clinical observations were 
recorded by laboratory personnel who were unbiased as to the design of the experiment. 
Preparation of Tissue  for Light and Electron Microscopy.  On day 45 after infection, mice 
were anesthetized with pentobarbital given intraperitoneally and then were sacrificed by 
intracardiac perfusion of phosphate-buffered 4% formaldehyde containing  1.5% glutar- 
aldehyde (pH  7.2).  Spinal cords were sectioned coronally into  15-20  blocks (1-2-ram- 
thick) and embedded in  2-hydroxyethyl methacrylate by using the JB4 system (Polysci- 
ences, Inc., Warrington, PA). Semithin sections were made and stained with a modified 
H  and  E  method  to  detect  inflammatory infiltrates  or  with  our  modification  of the 
Erichrome method to stain myelin (17). 
Selected spinal cord blocks were postfixed for 2 h in osmium tetroxide, dehydrated in 
graded alcohols, rinsed  in  propylene oxide, and embedded in  Araldite.  Selected areas 
were trimmed, and ukrathin sections were cut and examined by electron microscopy. 622  THE1LER'S  VIRUS-INDUCED  DEMYELINAT1ON 
TABLE  I 
Mapping  of Susceptible Gene to D ~ in  TMEV-induced  Demyelination 
Inflammation 
Strain  K  A  E  S  D  and  demyelin-  Paralysis* 
ation* 
B10.S  s  s  s  s  s  +  ++ 
BI0.D2  d  d  d  d  d  -  - 
B10.S (9R)  s  s  k  d  d  -  - 
B10.HTT  s  s  k  k  d  -  - 
BSVS  s  s  s  d  d  -  - 
B 10.S (7 R)  s  s  s  s  d  -  - 
B10.RSD2  s  s  s  s  d  -  - 
A.TH  s  s  s  s  d  -  - 
BI0  b  b  b  b  b  -  - 
BIO.RSBI  s  s  s  s  b  -  - 
B IO.S (26R)  s  s  s  s  b  -  - 
BtO.ASR2  k  k  k  d  s  +  +++ 
A.TBR  13  s  k  k  b  b  -  - 
*  Determined  by  examining  15-20  spinal  cord  sections  from  each  animal.  +,  inflammatory  cells 
alongside demyelinated  axons in all animals examined;  -,  no demyelination  or inflammation. 
+++,  paralysis or death  in >40%  of mice inoculated  with TMEV;  ++,  paralysis or death  in  20- 
40%  of mice;  +,  minimal  neurologic  deficits  in  <20%  of mice;  -,  no  clinical abnormafities  and 
100% survival. 
Results 
Influence  of H-2D  End.  Mice  (A.SW,  B10.S,  B10.RSS,  SJL/J)  with  H-2 s 
haplotype  were particularly  susceptible to TMEV-induced  demyelination.  Ge- 
netic experiments using recombinant mouse strains involving a susceptible hap- 
Iotype (H-2 s) and resistant haplotypes (H-2 ~, H-2 e, H-2  b) indicated that genes in 
the H-2D end determine susceptibility or resistance to the demyelinating effects 
of TMEV (Table I). TMEV-infected B10.ASR2 mice that express the D ~ gene 
product  but  have  resistant  alleles  in  K,  I,  and  S  regions  showed  prominent 
demyelination,  inflammation  within  the spinal cord white matter,  and paralysis 
in >40% of animals.  In contrast to these findings,  mice that expressed D d or D b 
genes  showed  no  demyelination,  inflammation,  or paralysis,  even  if they also 
expressed K ~, P, or S ~ genes (Table 1). 
Previous experiments have shown that  mice with q, v, p, or f  H-2 haplotype 
are susceptible to TMEV-induced demyelination,  and these animals  frequently 
show clinical abnormalities (17). We tested to determine if the D region was also 
controlling  susceptibility  to  demyelination  in  these  haplotypes  (Table  II). 
B10.AKM and B10.MBR strains with a susceptible D q allele but resistant k or b 
allele at the K, I, or S locus showed demyelination and inflammation in the white 
matter of the spinal cord in all animals tested. Similar pathologic findings were 
observed in  B10.SM  (22R) and  B10.F (14R) mice with a  susceptible D v or D p 
gene, respectively, but with a resistant k or b allele in other regions. In contrast, 
B10.F (13R) (KPIPD  b)  mice, which are the reciprocal of B10.F (14R)  (KblbO  p) 
mice, showed no pathologic abnormalities, indicating the strong D region control 
of susceptibility to demyelination. Analogous findings were also seen in A.TFR 1 
(K~IkSkDr) mice that were susceptible. 
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TABLE  II 
D Region Control of Susceptibility to Demyelination in q, v, p, andfHaplotypes 
Inflammation 
Strain  K  A  E  S  D  and demyelin-  Paralysis 
ation* 
B10.K  k  k  k  k  k  -  - 
BI0.Q  q  q  q  q  q  +  + 
B10.AKM  k  k  k  k  q  +  +++ 
B10.MBR  b  k  k  k  q  +  +++ 
B10.SM  v  v  v  v  v  +  + 
B10.SM (22R)  k  k  k  v  v  +  + 
B10.F  p  p  p  p  p  +  + 
B10.F (14R)  b  b  b  p  p  +  +++ 
BI0.F (13R)  p  p  p  b  b  -  - 
B10.M  f  f  f  f  f  +  ++ 
A.CA  f  f  f  f  f  +  + 
A.TFR5  f  f  f  k  d  -  - 
A.TFR1  s  k  k  k  f  +  +++ 
* See footnotes to Table I. 
TABLE  IIl 
Absence of Role of Qa and Tla Genes in TMEV-induced Demyelination 
Inflammation 
Strain  H-2  Qa-2  Tla  Pgk  Upg  and demyelin-  Paralysis* 
ation* 
A.CA  f  b  d  b  f  +  + 
B6.AC1  f  a  b  a  s  +  + 
B6  b  a  b  a  s  -  - 
B6.AC2  b  a  d  b  f  -  - 
B6.K1  b  a  b  b  f  -  - 
B6.K2  b  a  a  b  f  -  - 
B6.T1  (+)  b  a  a  a  s  -  - 
* See footnotes to Table I. 
right  of the  D  region  (Qa,  Tla,  Pgk,  UpG)  in  TMEV-induced  demyelination 
(Table III). In the strains tested, the haplotype expressed on the H-2 region was 
the critical  determinant  controlling  susceptibility to demyelination.  A.CA and 
B6.AC 1 mice with susceptible H-2 r haplotype showed pathologic abnormalities 
even though  these mice had  alleles from resistant  haplotypes to the right  (Qa, 
Tla  genes) of the  D  region.  Similarly,  B6.AC2,  B6.K1,  B6.K2, and  B6.TL(+) 
mice with the resistant [-t-2  b haplotype did not show inflammation or demyelin- 
ation in the spinal cord, despite expression of different genes to the right of H- 
2D.  Therefore,  genes mapping  to the right  of the  D  region  did not influence 
susceptibility or resistance to demyelination by TMEV. 
Mutation in the H-2D Gene(s) Alters Demyelination.  To define the relationship 
between  the  D  region  loci  and  virus-induced  demyelination,  we  inoculated 
B10.D2  dml  and  BALB/c-dm2 mice which are known to contain  deletion muta- 
tions in the D region (Fig. 1) (22). Recent data indicate that, in the dml mutation, 
the 5' exons of the D d gene are joined with 3' exons of the L a gene so that there 
is a deletion of part of the D and L genes along with any other genes between D 624  THEILER'S  VIRUS-INDUCED  DEMYELINATION 
D ~lenes 
Strain  K  I  S  D  (R)  L 
BIO. D2  d  d  d 
elO. D2 din1  d  d  d  ~'  ......... 
BIO. D2 (R106)  b  b  b  ~'~  .........  [-"7 
BALB/c-H-2 din2  d  d  d  [~"//JJ-~ .......... 
Inflamma- 
tion and 
damyelina- 
lion*  Paralysis* 
+  +++ 
+  ++ 
BALB/c  d  d  d 
FIGURE  1.  Mutation in  H-2D region genes alters susceptibility to virus-induced demyelina- 
tion.  In mice with the dml  and R106(SH)  mutation, the 5'  gene of D d is joined with the 3' 
gene of L d so that the 3' end of D d, the 5' end of L a, and the DNA between these genes are 
deleted. The (R) gene product has not been identified but is presumed to be a class 1 protein. 
The BALB/c-H-2  aml lacks detectable H-2R and H-2L products. 
* See footnotes to Table I. 
and L (23, 24). In contrast, the BALB/c-dm2 mouse has a complete deletion of 
the  L  gene along with an  undefined region  of adjacent DNA  between  the  D 
gene and genes in the Qa region (25, 26). TMEV infection of the parent B 10.D2 
or BALB/c mice resulted in little or no inflammation or demyelination. In the 
spinal cords of some BALB/c mice there were occasional perivascular  lympho- 
cytes, but there was no demonstrable demyelination by 45 d. Similarly, BALB/c- 
dm2 mice did not show pathologic changes or clinical deficits.  In contrast, all 
B 10.D2 ~'''~ mice showed large numbers of inflammatory cells in the white matter, 
along with primary demyelination (Fig. 2); there was paralysis in 9 of 15 infected 
mice. The inflammation and demyelination frequently involved 75% of the area 
of the  spinal  cord  white matter.  This was confirmed in  a  recombinant strain, 
B 10.D2 (R 106) (KbDdml), that expresses the same deleted dml mutation (Fig. 1). 
These findings suggested that the 3' end ofD d controls resistance or susceptibility 
to TMEV infection (Fig.  1). 
Virology.  Results of studies to isolate virus from the infected spinal cord and 
brain  are  shown  in  Table  IV.  Infectious virus was not detected at  45  d  post- 
infection in  spinal  cord  or  brain  extracts  from  mouse strains  that showed  no 
demyelination or inflammation (B10.D2; B10). In contrast, 3.3 ×  102-1.7  ×  10  4 
PFUs  of virus  were  isolated per  gram  of central  nervous  system  tissue  from 
animals with pathologic abnormalities in the spinal cord. Higher virus titers were 
seen in the B10.D2 ~ml mutant mice, the strain that showed the most prominent 
destruction of white matter. 
IgG Titers Against Purified  Virus Antigen.  Immunogiobulin in the serum di- 
rected against TMEV was measured at time of sacrifice of mice with mutations 
in  the  H-2D  region  (Fig.  3).  Susceptible  B10.D2 am~  mice  (n  =  15)  had  a 
significantly higher serum titer to virus antigen than did resistant B10.D2  (n = 
15)  mice (student's t test; p  <  0.05).  Resistant BALB/c-dm2 mice (n =  5) had 
lower titers. However, in general there was less than a twofold dilution difference 
in  the  titers  between  susceptible  and  resistant  strains,  indicating  that  these 
differences may not be biologically significant. Both the resistant and the suscep- 
tible mice had much higher serum  antivirus titers compared with noninfected 
controls, indicating that both had replicated the virus and were able to mount 
an immune response to it. FIGURE 2.  (A) Large  number of perivascular inflammatory cells are within the spinal cord 
white matter of virus-infected B I 0.D2  d"' mouse. Note inflammatory cells making contact with 
the endothelial cells of blood vessel.  Glycol  methacrylate-embedded section stained with H 
and E; x  320. (B) Electron micrograph from a persistently infected B10.D2  dml mouse, showing 
plasma cell in intimate association with multiple myelinated and demyelinated axons within 
the spinal cord.  Note hyperactive astrocytic process (as) with abundant glial filaments. Ultra- 
thin sections stained with uranyl acetate and lead citrate; x  18,000. 
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TABLE  IV 
Isolation  of TMEV From Brain and Spinal Cords of Mice With 
Mutation in H-2D Region 
Inflammation  Mean log~0 of  Number of  and demyelina-  virus titer*  Strain  mice (n)  tion 
B10.D2  3  -  ND 
B10.D2 am~  5  +  3.52 
B10.D2 (R106)  5  +  2.87 
B10  5  -  ND 
* Titer was  PFU/g of central nervous system tissue.  Lower limit of the 
assay was 50 PFU/g. 
0.6 
:~0.5  -  dml 
•  ,=,  H-2 
.~ 
c 
0.4  -  "o 
.~  0.3  - 
0 
0.2  --  H.2dm2~A-~ 
0.1  --  N~ 
0  I  I  I  I  I 
800  1,600  3,200  6,400  12,800 
Reciprocal  of  dilution 
FIGURE 3.  Serum Ig titers against purified TMEV antigen in mice with mutations in H-2D 
region  molecules.  Higher titers  were  noted  in  B10.D2  °~"~ mice,  which were  susceptible to 
virus-induced demyelination. However, B 10. D2, BALB/c, and BALB/c-dm2 mice, which were 
resistant to demyelination, also had higher lg titers than did uninfected control mice. 
Discussion 
The  present  study  demonstrated  that  genes  determining  susceptibility  or 
resistance to demyelination by TMEV are located within the D region of the H- 
2 complex. Involvement of the K region was excluded because A.TBR 13 mice 
(K  s D b) did not show demyelination even though these mice express the suscep- 
tible K s allele (but the resistant D b gene). In these experiments there was not a 
strong  influence of the  I  region  in  determining demyelination or  infection. 
B10.ASR2,  B10.AKM,  B10.MBR,  B10.F(14R),  and  A.TFR1  with susceptible 
alleles in  the  D  gene  but  resistant  alleles  in  the  I  region  showed  pathologic 
abnormalities.  Similarly,  B10.F(13R),  A.TFR3,  and  B10.S(gR)  with  resistant 
alleles in the D gene but susceptible alleles in the I region did not demonstrate 
demyelination. In addition, genes to the right of the D region did not appear to 
be important in determining susceptibility to TMEV-induced demyelination. 
The results of TMEV-induced demyelination in mouse strains with mutations 
in the H-2D gene were of particular interest. B 10.D2 dm~ mice showed prominent RODRIGUEZ  ET  AL.  627 
inflammation, demyelination, and clinical deficits whereas the B10.D2  parent 
mice were normal. B10.D2 a''~ was derived from B10.D2 mice treated with the 
mutagen diethyl sulfate (27).  The mutation has been localized to the D region 
of H-2. Serologic and structural analyses indicate major alterations in the expres- 
sion of at least three H-2D/L-iinked antigens (23).  The mutant antigen appears 
to be a structural mosaic of two parental antigens such that the 5' end of the D d 
gene is joined with the 3' end ofL  a so that the 3' end of D d, the 5' end of L d, 
and the DNA between D and L are deleted (24).  The junction between the H- 
2D  d and H-2L d encoded structures within the H-2D/L dm~ encoded antigen seems 
to be the a-2  domain (28).  The difference in susceptibility to TMEV-induced 
demyelination between B10.D2 and B10.D2 dm~ suggests that the resistant gene 
must map to the 3' end of D, the DNA between D and L, or the 5' end of L. 
To map the susceptibility to demyelination more precisely within the D region, 
BALB/c-dm2 mice were inoculated with TMEV. This mutant differs from the 
parental BALB/c strain by lacking detectable H-2R and H-2L encoded products 
(25).  In contrast to the pathologic abnormalities noted in  the spinal cords of 
B10.D2 d'~ mice, the spinal cords of BALB/c-H-2  amz mice showed no abnormal- 
ities. 
The contrasting effects of TMEV infection in B10.D2  am~ and BALB/c-H-2  amz 
indicate that the 3' end of the D molecule is sufficient in determining resistance 
or  susceptibility to  demyelination. However,  because  the  deletions are  being 
compared in mice with different backgrounds, it is possible that a non-H-2 gene 
in BALB negates the effect of an R or L gene in inducing the susceptibility. The 
deletion of the 3' end of  the D gene in B 10.D2 dm~ also might cause a nonstructural 
but functional abnormality in the 5' end of the D gene, which then becomes the 
critical determinant in genetic susceptibility. In addition, other genes to the right 
of the D gene, which are deleted in dml but not in dm2, may be important. 
We  attempted  to  correlate  TMEV-specific  humorai  immunity to  TMEV- 
induced demyelination. The susceptible B10.D2 dm~ mutant mice did show higher 
serum  Ig titers directed against purified viral antigens than  did  the  resistant 
parental  B10.D2  strain.  The  BALB/c-dm2 deletion mutant showed lower  Ig 
titers to purified virus, but the titers were always higher than those in noninfected 
controls.  In our studies, there was a  strong correlation between the ability to 
isolate infectious virus from central nervous system tissue and susceptibility to 
demyelination. From the present virologic studies we cannot conclude whether 
the resistant strains are unable to infect central nervous system cells or there is 
rapid clearance of the virus by immune cells. The findings do indicate, however, 
a relationship between persistence of virus and destruction of white matter. This 
is in contrast to investigations by Clatch et al. (29)  that did not demonstrate a 
correlation between central nervous system TMEV titer and control of demye- 
lination by the H-2D region. Their studies used clinical rather than pathologic 
criteria to determine genetic susceptibility to disease. Because of the low inci- 
dence of clinical disease, they used crosses between SJL and several congeneic 
recombinant mouse strains bearing different combinations of H-2 genes. Disease 
incidence correlated with TMEV-specific delayed-type hypersensitivity but not 
with TMEV-specific humoral responses or T-cell proliferation. We are currently 
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The mechanism by which TMEV induces demyelination is not yet known. In 
previous experiments (14) we found production of virus antigen within persist- 
ently infected oligodendrocytes (14), the myelin-producing cell. TMEV antigen 
was present within the inner and outer oligodendroglial loops that connect with 
myelin lamellae (20, 30). It is possible that class I-restricted (e.g., H-2D) cytotoxic 
T  cells may attack antigen of the glial loops, thereby injuring infected oligoden- 
drocytes and  so  producing  demyelination.  This  hypothesis  may be  criticized 
because TMEV, as a member of the family Picornaviradae, is not known to bud 
from host cell surfaces and, therefore, may not insert virus-specific antigens into 
the cell membrane. However, some recent studies with coxsackievirus, another 
picornavirus, have shown cytotoxic T-cell responses against infected target cells 
(31).  Another possible mechanism of immune-mediated demyelination may be 
autoimmune attack of normal myelin, as in experimental autoimmune encepha- 
lomyelitis (32).  All attempts  to  transfer TMEV  demyelination adoptively into 
naive syngeneic recipients by injecting lymphocytes from TMEV-immune lymph 
nodes or spleens have failed (20, 33). Also, serum or immune cells from TMEV- 
infected mice fail to injure myelinating cultures (33). These results suggest that, 
in this model, the immunopathology of demyelination is different from that of 
experimental autoimmune encephalomyelitis and may require virus antigen as 
an immunologic stimulus. Myelin breakdown also may be the result of release of 
nonspecific proteases from macropbages during the interaction of immune cells 
and infected non-myelin-producing cells (i.e., innocent bystander demyelination) 
(34, 35). 
We can hypothesize that one of the D region genes (possibly an epitope on the 
3'  end of D a) is involved in preventing persistent TMEV infection within the 
central nervous system. This may occur by two possible mechanisms. In resistant 
strains, oligodendrocytes and other glial cells may not have receptors for TMEV, 
and therefore infection never occurs. This is unlikely because resistant strains 
develop a normal humorai response to the virus. More likely, the restricting class 
I gene products may be involved in generating a cytotoxic T-lymphocyte  response 
against TMEV, which prevents persistent viral infection in the central nervous 
system. In mice with susceptible haplotypes, class I H-2-encoded antigen may not 
be presented to the T  cells in association with virus antigen, thereby allowing 
the  virus  to  persist.  The  persistent  infection  may  generate  a  new  indolent 
immunopathologic response against viral antigens on oligodendrocytes or normal 
autoantigens on myelin or oligodendrocytes. Class  II antigens may be involved 
in this secondary phase of the disease because mAbs against Ia suppress demye- 
lination (14). 
Summary 
Demyelination induced by Theiler's virus was examined in mouse strains with 
congeneic recombinant haplotypes. Light and electron microscopy of spinal cord 
sections  from  mice  with  s,  q,  v,  p,  and f  H-2D  alleles  showed  perivascular 
inflammation and primary demyelination. The presence of susceptible haplotypes 
in  the K or I  region did not correlate with pathologic abnormalities. The Qa, 
Tla, PgK, and UpG genes did not appear to be critical in determining susceptibility 
to disease.  However, mutation in  the H-2D genes altered the susceptibility to RODRIGUEZ  ET  AL.  629 
virus-induced  demyelination.  B10.D2 a'l  mice,  which  have  deletions  in  the  3' 
end of D a and the  5'  end  of L d,  showed prominent demyelination  and  clinical 
deficits.  In contrast,  BALB/c-dm2, which have a  deletion of the entire L  gene, 
showed  no  pathologic  changes.  Central  nervous  system  virus  titers  correlated 
with susceptibility to demyelination;  both resistant and susceptible strains had a 
strong  humoral  immune  response  to  the  virus.  The  findings  in  the  congeneic 
recombinant mice and in mice mutant in the H-2D region strongly suggest that 
at  least one  of the  genes  critical  for  determining  virus-induced  demyelination 
maps to the  3' end of the H-2D gene. 
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